Xechem International Inc. (XKEMQ/XKEMQ.PK) Wrap Up:

Xechem International, Inc., a biopharmaceutical company, engages in the research, development, and production of generic and proprietary drugs from natural sources. Its principal product under development is NICOSAN/HEMOXIN, which would be used for the treatment of sickle cell disease. The company also applies its proprietary extraction, isolation, and purification technology to the production and manufacture of Paclitaxel, which is an anti-cancer compound used for the treatment of ovarian, breast, small cell lung cancers, and AIDS-related kaposi sarcomas. In addition, Xechem International engages in the research and development of other compounds using traditional medicinal plants, microbia...